Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Asset Writedowns and Impairment (2017 - 2025)

Integra Lifesciences Holdings' Asset Writedowns and Impairment history spans 9 years, with the latest figure at $511.4 million for Q2 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 10038.08% to $511.4 million in Q2 2025 year-over-year; TTM through Dec 2025 was $511.4 million, a 2552.31% increase, with the full-year FY2025 number at $511.4 million, up 4088.43% from a year prior.
  • Asset Writedowns and Impairment hit $511.4 million in Q2 2025 for Integra Lifesciences Holdings, up from $36000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for IART hit a ceiling of $511.4 million in Q2 2025 and a floor of $36000.0 in Q4 2024.
  • Historically, Asset Writedowns and Impairment has averaged $88.9 million across 3 years, with a median of $6.1 million in 2024.
  • The widest YoY moves for Asset Writedowns and Impairment: up 10038.08% in 2025, down 10038.08% in 2025.
  • Tracing IART's Asset Writedowns and Impairment over 3 years: stood at $2.8 million in 2021, then tumbled by 98.69% to $36000.0 in 2024, then soared by 1420358.33% to $511.4 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for IART at $511.4 million in Q2 2025, $36000.0 in Q4 2024, and $7.1 million in Q3 2024.